{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:09:34Z","timestamp":1793318974995,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005936","name":"International Society for Heart and Lung Transplants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005936","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019832","name":"Gal\u00e1pagos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003284","name":"Pulmonary Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003284","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013607","name":"American College of Clinical Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006591","name":"FibroGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.chest.2022.02.012","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T21:57:19Z","timestamp":1644875839000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease"],"prefix":"10.1016","volume":"162","author":[{"given":"Franck F.","family":"Rahaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Kolaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji","family":"Adegunsoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao A.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Scholand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana A.","family":"Shlobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2022.02.012_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2022.02.012_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211005641","article-title":"Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life","volume":"11","author":"DuBrock","year":"2021","journal-title":"Pulm Circ"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1378\/chest.08-2306","article-title":"Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension","volume":"136","author":"Mej\u00eda","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12890-016-0207-3","article-title":"Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study","volume":"16","author":"Takahashi","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.chest.2022.02.012_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.00115511","article-title":"Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"40","author":"Judge","year":"2012","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2022.02.012_bib9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.rmed.2012.07.013","article-title":"Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis","volume":"106","author":"Minai","year":"2012","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12890-019-0880-0","article-title":"Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience","volume":"19","author":"Kawamura","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.chest.2022.02.012_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCP.0000000000000599","article-title":"Pulmonary hypertension due to interstitial lung disease","volume":"25","author":"King","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.chest.2022.02.012_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.06-1466","article-title":"Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis","volume":"131","author":"Hamada","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000345221","article-title":"Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis","volume":"85","author":"Kimura","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.chest.2022.02.012_bib15","doi-asserted-by":"crossref","first-page":"w14363","DOI":"10.4414\/smw.2016.14363","article-title":"Pulmonary hypertension associated with chronic lung diseases","volume":"146","author":"Funke","year":"2016","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200604-520OC","article-title":"Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis","volume":"174","author":"Lederer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.06-2485","article-title":"Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis","volume":"131","author":"Nathan","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2022.02.012_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1183\/09031936.00107206","article-title":"Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant","volume":"30","author":"Shorr","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2022.02.012_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1378\/chest.12-2298","article-title":"Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis","volume":"144","author":"Rivera-Lebron","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.chest.2022.02.012_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmed.2017.00123","article-title":"Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management","volume":"4","author":"Oldham","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.chest.2022.02.012_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2022.02.012_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/resp.13250","article-title":"Pulmonary hypertension in interstitial lung disease: limitations of echocardiography compared to cardiac catheterization","volume":"23","author":"Keir","year":"2018","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.chest.2022.02.012_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCP.0000000000000790","article-title":"Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment","volume":"27","author":"Behr","year":"2021","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2022.02.012_bib26","series-title":"Group Techniques for Program Planning","author":"Delbecq","year":"1975"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1108\/09654280310459112","article-title":"The Delphi method and health research","volume":"103","author":"de Meyrick","year":"2003","journal-title":"Health Education"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib28","first-page":"1","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Practical Assessment, Research & Evaluation"},{"issue":"5","key":"10.1016\/j.chest.2022.02.012_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2022.02.012_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J\u00a0Adv Nurs"},{"issue":"1","key":"10.1016\/j.chest.2022.02.012_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1086\/690109","article-title":"Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project","volume":"7","author":"Rahaghi","year":"2017","journal-title":"Pulm Circ"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2045893217721695","article-title":"Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): a Delphi consensus document","volume":"7","author":"Rahaghi","year":"2017","journal-title":"Pulm Circ"},{"issue":"5","key":"10.1016\/j.chest.2022.02.012_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"},{"issue":"2 Suppl 58","key":"10.1016\/j.chest.2022.02.012_bib34","first-page":"S47","article-title":"Interactions between rheumatologists and cardio-\/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis","volume":"28","author":"Huscher","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.23718","article-title":"Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis","volume":"59","author":"Distler","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.chest.2022.02.012_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/11795484211006050","article-title":"Delphi consensus recommendations on management of dosing, adverse events, and comorbidities in the treatment of idiopathic pulmonary fibrosis with nintedanib","volume":"15","author":"Rahaghi","year":"2021","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.chest.2022.02.012_bib37","doi-asserted-by":"crossref","first-page":"101979","DOI":"10.1016\/j.pupt.2020.101979","article-title":"An expert panel Delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil","volume":"66","author":"Rahaghi","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/aos.14702","article-title":"Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi study","volume":"99","author":"Nguyen","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.chest.2022.02.012_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.chest.2022.02.012_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"Corte","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2022.02.012_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.chest.2022.02.012_bib42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib43","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1378\/chest.12-1594","article-title":"Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction","volume":"143","author":"Han","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2022.02.012_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.chest.2020.02.016","article-title":"A randomized, double-blind, placebo-controlled study of pulsed, inhaled nitric oxide in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis","volume":"158","author":"Nathan","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.chest.2022.02.012_bib45","series-title":"A\u00a0study to assess pulsed inhaled nitric oxide in subjects with pulmonary fibrosis at risk for pulmonary hypertension (REBUILD). NCT03267108. ClinicalTrials.gov","year":"2021"},{"issue":"4","key":"10.1016\/j.chest.2022.02.012_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib47","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.07-2488","article-title":"Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"133","author":"Zisman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.chest.2022.02.012_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rmed.2016.06.001","article-title":"Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"117","author":"Alkukhun","year":"2016","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.chest.2022.02.012_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/crj.13059","article-title":"Multimodal noninvasive prediction of pulmonary hypertension in IPF","volume":"13","author":"Sonti","year":"2019","journal-title":"Clin Respir J"},{"issue":"3","key":"10.1016\/j.chest.2022.02.012_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x","article-title":"Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"16","author":"Swigris","year":"2011","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.chest.2022.02.012_bib51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.semarthrit.2018.10.010","article-title":"Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension","volume":"48","author":"Young","year":"2019","journal-title":"Semin Arthritis Rheum"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222002628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222002628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:03:07Z","timestamp":1762124587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222002628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0012369222002628"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.02.012","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}